EDESA BIOTECH, INC. Loans Payable, Noncurrent
EDESA BIOTECH, INC. (EDSA) had Loans Payable, Noncurrent of $0 as of 2023-09-30, per its 10-K filed 2023-12-15.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2023-12-15
- 2023-09-30: Loans Payable, Noncurrent $0.00.
- 2022-09-30: Loans Payable, Noncurrent $43.66K.
- 2021-09-30: Loans Payable, Noncurrent $47.20K.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2023-09-30 | $0.00 10-K · filed 2023-12-15 |
| 2022-09-30 | $43.66K 10-K · filed 2023-12-15 |
| 2021-09-30 | $47.20K 10-K · filed 2022-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B |